Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 79 Pages
Report ld: 3948997
Request Sample
Customized Report
The global Oxfendazole market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Oxfendazole is a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms. Oxfendazole is the sulfoxide metabolite of fenbendazole. Oxfendazole is an anthelmintic (wormer) compound used in veterinary practice.
The North America Oxfendazole market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Oxfendazole include Alivira Animal Health, Bazayan, Wuhan Dahua Pharmaceutical, Jiangsu Baozong & Baoda Pharmachem, Shanxi Hanjiang pharmaceutical, Lasa Laboratory, Jiangsu Quality Horizons Pharmtech, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Oxfendazole market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oxfendazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Oxfendazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Oxfendazole manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxfendazole revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Oxfendazole Product Scope
1.2 Oxfendazole by Type
1.2.1 Global Oxfendazole Sales by Type (2020 & 2024 & 2031)
1.2.2 ≥98%
1.2.3 ≥99%
1.2.4 Other
1.3 Oxfendazole by Application
1.3.1 Global Oxfendazole Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Powder
1.3.3 Solution
1.4 Global Oxfendazole Market Estimates and Forecasts (2020-2031)
1.4.1 Global Oxfendazole Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Oxfendazole Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Oxfendazole Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Oxfendazole Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Oxfendazole Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Oxfendazole Sales Market Share by Region (2020-2025)
2.2.2 Global Oxfendazole Revenue Market Share by Region (2020-2025)
2.3 Global Oxfendazole Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Oxfendazole Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Oxfendazole Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Oxfendazole Market Size and Prospective (2020-2031)
2.4.2 Europe Oxfendazole Market Size and Prospective (2020-2031)
2.4.3 China Oxfendazole Market Size and Prospective (2020-2031)
2.4.4 Japan Oxfendazole Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Oxfendazole Historic Market Review by Type (2020-2025)
3.1.1 Global Oxfendazole Sales by Type (2020-2025)
3.1.2 Global Oxfendazole Revenue by Type (2020-2025)
3.1.3 Global Oxfendazole Price by Type (2020-2025)
3.2 Global Oxfendazole Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Oxfendazole Sales Forecast by Type (2026-2031)
3.2.2 Global Oxfendazole Revenue Forecast by Type (2026-2031)
3.2.3 Global Oxfendazole Price Forecast by Type (2026-2031)
3.3 Different Types Oxfendazole Representative Players
4 Global Market Size by Application
4.1 Global Oxfendazole Historic Market Review by Application (2020-2025)
4.1.1 Global Oxfendazole Sales by Application (2020-2025)
4.1.2 Global Oxfendazole Revenue by Application (2020-2025)
4.1.3 Global Oxfendazole Price by Application (2020-2025)
4.2 Global Oxfendazole Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Oxfendazole Sales Forecast by Application (2026-2031)
4.2.2 Global Oxfendazole Revenue Forecast by Application (2026-2031)
4.2.3 Global Oxfendazole Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Oxfendazole Application
5 Competition Landscape by Players
5.1 Global Oxfendazole Sales by Players (2020-2025)
5.2 Global Top Oxfendazole Players by Revenue (2020-2025)
5.3 Global Oxfendazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxfendazole as of 2024)
5.4 Global Oxfendazole Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Oxfendazole, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Oxfendazole, Product Type & Application
5.7 Global Key Manufacturers of Oxfendazole, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Oxfendazole Sales by Company
6.1.1.1 North America Oxfendazole Sales by Company (2020-2025)
6.1.1.2 North America Oxfendazole Revenue by Company (2020-2025)
6.1.2 North America Oxfendazole Sales Breakdown by Type (2020-2025)
6.1.3 North America Oxfendazole Sales Breakdown by Application (2020-2025)
6.1.4 North America Oxfendazole Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Oxfendazole Sales by Company
6.2.1.1 Europe Oxfendazole Sales by Company (2020-2025)
6.2.1.2 Europe Oxfendazole Revenue by Company (2020-2025)
6.2.2 Europe Oxfendazole Sales Breakdown by Type (2020-2025)
6.2.3 Europe Oxfendazole Sales Breakdown by Application (2020-2025)
6.2.4 Europe Oxfendazole Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Oxfendazole Sales by Company
6.3.1.1 China Oxfendazole Sales by Company (2020-2025)
6.3.1.2 China Oxfendazole Revenue by Company (2020-2025)
6.3.2 China Oxfendazole Sales Breakdown by Type (2020-2025)
6.3.3 China Oxfendazole Sales Breakdown by Application (2020-2025)
6.3.4 China Oxfendazole Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Oxfendazole Sales by Company
6.4.1.1 Japan Oxfendazole Sales by Company (2020-2025)
6.4.1.2 Japan Oxfendazole Revenue by Company (2020-2025)
6.4.2 Japan Oxfendazole Sales Breakdown by Type (2020-2025)
6.4.3 Japan Oxfendazole Sales Breakdown by Application (2020-2025)
6.4.4 Japan Oxfendazole Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Alivira Animal Health
7.1.1 Alivira Animal Health Company Information
7.1.2 Alivira Animal Health Business Overview
7.1.3 Alivira Animal Health Oxfendazole Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Alivira Animal Health Oxfendazole Products Offered
7.1.5 Alivira Animal Health Recent Development
7.2 Bazayan
7.2.1 Bazayan Company Information
7.2.2 Bazayan Business Overview
7.2.3 Bazayan Oxfendazole Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Bazayan Oxfendazole Products Offered
7.2.5 Bazayan Recent Development
7.3 Wuhan Dahua Pharmaceutical
7.3.1 Wuhan Dahua Pharmaceutical Company Information
7.3.2 Wuhan Dahua Pharmaceutical Business Overview
7.3.3 Wuhan Dahua Pharmaceutical Oxfendazole Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Wuhan Dahua Pharmaceutical Oxfendazole Products Offered
7.3.5 Wuhan Dahua Pharmaceutical Recent Development
7.4 Jiangsu Baozong & Baoda Pharmachem
7.4.1 Jiangsu Baozong & Baoda Pharmachem Company Information
7.4.2 Jiangsu Baozong & Baoda Pharmachem Business Overview
7.4.3 Jiangsu Baozong & Baoda Pharmachem Oxfendazole Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Jiangsu Baozong & Baoda Pharmachem Oxfendazole Products Offered
7.4.5 Jiangsu Baozong & Baoda Pharmachem Recent Development
7.5 Shanxi Hanjiang pharmaceutical
7.5.1 Shanxi Hanjiang pharmaceutical Company Information
7.5.2 Shanxi Hanjiang pharmaceutical Business Overview
7.5.3 Shanxi Hanjiang pharmaceutical Oxfendazole Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Shanxi Hanjiang pharmaceutical Oxfendazole Products Offered
7.5.5 Shanxi Hanjiang pharmaceutical Recent Development
7.6 Lasa Laboratory
7.6.1 Lasa Laboratory Company Information
7.6.2 Lasa Laboratory Business Overview
7.6.3 Lasa Laboratory Oxfendazole Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Lasa Laboratory Oxfendazole Products Offered
7.6.5 Lasa Laboratory Recent Development
7.7 Jiangsu Quality Horizons Pharmtech
7.7.1 Jiangsu Quality Horizons Pharmtech Company Information
7.7.2 Jiangsu Quality Horizons Pharmtech Business Overview
7.7.3 Jiangsu Quality Horizons Pharmtech Oxfendazole Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Jiangsu Quality Horizons Pharmtech Oxfendazole Products Offered
7.7.5 Jiangsu Quality Horizons Pharmtech Recent Development
8 Oxfendazole Manufacturing Cost Analysis
8.1 Oxfendazole Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Oxfendazole
8.4 Oxfendazole Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Oxfendazole Distributors List
9.3 Oxfendazole Customers
10 Oxfendazole Market Dynamics
10.1 Oxfendazole Industry Trends
10.2 Oxfendazole Market Drivers
10.3 Oxfendazole Market Challenges
10.4 Oxfendazole Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Oxfendazole was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 129
USD 3950.00
(Single User License)
The global Oxfendazole market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 128
USD 2900.00
(Single User License)
The global Oxfendazole market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 139
USD 4900.00
(Single User License)
The global market for Oxfendazole was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 109
USD 3950.00
(Single User License)
The global market for Oxfendazole was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 90
USD 2900.00
(Single User License)
Oxfendazole is a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms. Oxfendazole is the sulfoxide metabolite of fenbendazole. Oxfendazole is an anthelmintic (wormer) compound used in veterinary practice.
Published Date: 2024-04-08
Pages: 92
USD 4900.00
(Single User License)
Oxfendazole is a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms. Oxfendazole is the sulfoxide metabolite of fenbendazole. Oxfendazole is an anthelmintic (wormer) compound used in veterinary practice.
Published Date: 2024-02-22
Pages: 95
USD 3950.00
(Single User License)
Oxfendazole is a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms. Oxfendazole is the sulfoxide metabolite of fenbendazole. Oxfendazole is an anthelmintic (wormer) compound used in veterinary practice.
Published Date: 2024-01-16
Pages: 87
USD 2900.00
(Single User License)
The global market for Oxfendazole was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 129
The global Oxfendazole market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 128
The global Oxfendazole market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 139
The global market for Oxfendazole was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 109
The global market for Oxfendazole was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 90
Oxfendazole is a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms. Oxfendazole is the sulfoxide metabolite of fenbendazole. Oxfendazole is an anthelmintic (wormer) compound used in veterinary practice.
Published: 2024-04-08
Pages: 92
Oxfendazole is a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms. Oxfendazole is the sulfoxide metabolite of fenbendazole. Oxfendazole is an anthelmintic (wormer) compound used in veterinary practice.
Published: 2024-02-22
Pages: 95
Oxfendazole is a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms. Oxfendazole is the sulfoxide metabolite of fenbendazole. Oxfendazole is an anthelmintic (wormer) compound used in veterinary practice.
Published: 2024-01-16
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now